Immucell Corp
$9.880
USD
Last updated on --.
24h volume10.21K
24h highest10.0500 USD
24h lowest9.7400 USD
24h Price movement+0.92%
ICCC recent prices
24 Hours
+0.92%+$0.09
30 days
+10.29%+$0.915
60 days
+48.34%+$3.195
90 days
+48.56%+$3.205
Key data
Previous close9.7900 USD
Market cap92.64M USD
Volume10.21K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.06000 USD
Net income (FY)-545.40K USD
Revenue (FY)29.93M USD
Last report dateMay 14, 2026
About Immucell Corp
HeadquartersPORTLAND
Employees (FY)73.00
Revenue per employee (FY)410.06K USD
Net income per employee (FY)-7.47K USD
Listed onNasdaq
ICCC conversion tables
 |  |
|---|---|
| 0.5 ICCC | 4.940 USD |
| 1 ICCC | 9.880 USD |
| 5 ICCC | 49.4 USD |
| 10 ICCC | 98.8 USD |
| |
|---|---|
| 0.5 USD | 0.050607 ICCC |
| 1 USD | 0.10121 ICCC |
| 5 USD | 0.50607 ICCC |
| 10 USD | 1.012 ICCC |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
ICCC is trading at $9.880, +0.92% over the last 24 hours. Track live moves on the price chart at the top of this page.
The ICCC stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. ICCC is currently trading at $9.880, +0.92% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on ICCC price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. ICCC's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from ICCC; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against ICCC's historical range and other companies in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector.
Immucell Corp's market cap is currently 92.64M USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume10.21K
24h highest10.0500 USD
24h lowest9.7400 USD
24h Price movement+0.92%
Start trade with ICCC Perpetual
Sign up to trade